Skip to main content
Log in

Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board

  • Current Opinion
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Poor adherence to treatment regimens has long been recognized as a substantial roadblock to achieving better outcomes for patients. Non-adherence to medications affects the quality and length of life and has been associated with negative health outcomes and increasing healthcare costs. The problem of non-adherence is particularly troublesome in older patients who are affected by multiple chronic diseases and for this reason receive multiple treatments. To date, no single intervention strategy has been shown to be effective in improving adherence across all patients, conditions, and settings. Between September and October 2014, a group of experts in geriatrics, pharmacology, epidemiology, and public health applied a modified RAND appropriateness method to reach a consensus on the possible best interventions to improve adherence in older individuals. Seven interventions were identified, classified based on their target (patient, therapy, and public health/society): (1) Comprehensive Geriatric Assessment, (2) patient (and caregiver) education to improve patient empowerment, (3) optimization of treatment, (4) use of adherence aids, (5) physician and other healthcare professionals’ education, (6) adherence assessment, (7) facilitating access to medicine by service integration. For each intervention, experts assessed (a) target population, (b) health professionals potentially involved in the intervention, (c) strategies/instruments needed for implementation, and (d) time of the intervention. Interventions that target adherence must combine different approaches targeting the complex aspects of older adults in a holistic approach. Tackling non-adherence, with its complexity, requires a multi-stakeholder patient-centred approach acting in a defined framework of interactions in which the different players may provide different services but are integrated with one another.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–9.

    Article  PubMed  Google Scholar 

  2. Carlson C, Merel SE, Yukawa M. Geriatric syndromes and geriatric assessment for the generalist. Med Clin North Am. 2015;99(2):263–79.

    Article  PubMed  Google Scholar 

  3. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–12.

    Article  CAS  PubMed  Google Scholar 

  4. Marengoni A, Onder G. Guidelines, polypharmacy, and drug–drug interactions in patients with multimorbidity. BMJ. 2015;350:h1059.

    Article  PubMed  Google Scholar 

  5. Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40.

    Article  PubMed  Google Scholar 

  6. Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc. 2010;58(9):1791–6.

    Article  PubMed  Google Scholar 

  7. Onder G, Bonassi S, Abbatecola AM, Geriatrics Working Group of the Italian Medicines Agency, et al. High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci. 2014;69(4):430–7.

    Article  PubMed  Google Scholar 

  8. Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012;62(605):e821–6.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Fialová D, Topinková E, Gambassi G, AdHOC Project Research Group, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.

    Article  PubMed  Google Scholar 

  10. Salvi F, Marchetti A, D’Angelo F, et al. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35(Suppl 1):29–45.

    Article  PubMed  Google Scholar 

  11. Sabatè E. Adherence to long-term therapies: evidence for action. Geneva:World Health Organization; 2003. http://www.who.int/chp/knowledge/publications/adherence_report/en/.

  12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  CAS  PubMed  Google Scholar 

  13. Calderón-Larrañaga A, Diaz E, Poblador-Plou B, et al. Non-adherence to antihypertensive medication: the role of mental and physical comorbidity. Int J Cardiol. 2016;207:310–6.

    Article  PubMed  Google Scholar 

  14. Oosterom-Calo R, van Ballegooijen AJ, Terwee CB, et al. Determinants of adherence to heart failure medication: a systematic literature review. Heart Fail Rev. 2013;18(4):409–27.

    Article  CAS  PubMed  Google Scholar 

  15. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.

    Article  CAS  PubMed  Google Scholar 

  16. Stevenson FA, Cox K, Britten N, et al. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7(3):235–45.

    Article  PubMed  Google Scholar 

  17. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811.

    Article  PubMed  Google Scholar 

  18. Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44.

    PubMed  PubMed Central  Google Scholar 

  19. Roebuck MC, Liberman JN, Gemmill-Toyama M, et al. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1):91–9.

    Article  Google Scholar 

  20. Costa E, Giardini A, Savin M, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adher. 2015;9:1303–14.

    Article  Google Scholar 

  21. Giardini A, Martin MT, Cahir C, et al. Toward appropriate criteria in medication adherence assessment in older persons: position paper. Aging Clin Exp Res. 2016;28(3):371–81.

    Article  PubMed  Google Scholar 

  22. Stuck AE, Iliffe S. Comprehensive geriatric assessment for older adults. BMJ. 2011;343:d6799.

    Article  PubMed  Google Scholar 

  23. Ellis G, Whitehead MA, Robinson D, et al. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ. 2011;343:d6553.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116(6):394–401.

    Article  PubMed  Google Scholar 

  25. Onder G, van der Cammen TJ, Petrovic M, et al. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42(3):284–91.

    Article  PubMed  Google Scholar 

  26. Bernabei R, Landi F, Onder G, et al. Second and third generation assessment instruments: the birth of standardization in geriatric care. J Gerontol A Biol Sci Med Sci. 2008;63(3):308–13.

    Article  PubMed  Google Scholar 

  27. van de Pol MH, Fluit CR, Lagro J, et al. Expert and patient consensus on a dynamic model for shared decision-making in frail older patients. Patient Educ Couns. 2016;99(6):1069–77.

    Article  PubMed  Google Scholar 

  28. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.

    Article  PubMed  Google Scholar 

  29. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–44.

    Article  PubMed  Google Scholar 

  30. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.

    Article  CAS  PubMed  Google Scholar 

  31. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227–46.

    Article  Google Scholar 

  32. Boeni F, Spinatsch E, Suter K, et al. Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Syst Rev. 2014;3:29.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Stegemann S, Baeyens JP, Cerreta F, et al. Adherence measurement systems and technology for medications in older patient populations. Eur Geriatr Med. 2012;3:254–60.

    Article  Google Scholar 

  34. Strandbygaard U, Thomsen SF, Backer V. A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir Med. 2010;104(2):166–71.

    Article  PubMed  Google Scholar 

  35. Foppa AA, Chemello C, Vargas-Peláez CM, et al. Medication therapy management service for patients with Parkinson’s disease: a before-and-after study. Neurol Ther. 2016;5(1):85–99.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Makai P, Perry M, Robben SH, et al. Evaluation of an eHealth intervention in chronic care for frail older people: why adherence is the first target. J Med Internet Res. 2014;16(6):e156.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandra Marengoni.

Ethics declarations

Funding

Senior Italia Federanziani sponsored the meeting of the experts. The funder had no role in study design, data collection, decision to publish, or preparation of the manuscript.

Conflict of interest

Alessandra Marengoni, Alessandro Monaco, Elisio Costa, Antonio Cherubini, Alexandra Prados-Torres, Christiane Muth, Renè J.F. Melis, Luca Pasina, Tischa J.M. van der Cammen, Katie Palmer, Sergio Pecorelli, and Graziano Onder declare they have no conflicts of interest relevant to the content of this article.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 35 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marengoni, A., Monaco, A., Costa, E. et al. Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board. Drugs Aging 33, 629–637 (2016). https://doi.org/10.1007/s40266-016-0387-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-016-0387-9

Keywords

Navigation